Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, CA, USA.
Neuroimage Clin. 2021;29:102574. doi: 10.1016/j.nicl.2021.102574. Epub 2021 Jan 26.
Neurological and psychiatric illnesses are associated with regional brain deficit patterns that bear unique signatures and capture illness-specific characteristics. The Regional Vulnerability Index (RVI) was developed toquantify brain similarity by comparing individual white matter microstructure, cortical gray matter thickness and subcortical gray matter structural volume measures with neuroanatomical deficit patterns derived from large-scale meta-analytic studies. We tested the specificity of the RVI approach for major depressive disorder (MDD) and Alzheimer's disease (AD) in a large epidemiological sample of UK Biobank (UKBB) participants (N = 19,393; 9138 M/10,255F; age = 64.8 ± 7.4 years). Compared to controls free of neuropsychiatric disorders, participants with MDD (N = 2,248; 805 M/1443F; age = 63.4 ± 7.4) had significantly higher RVI-MDD values (t = 5.6, p = 1·10), but showed no detectable difference in RVI-AD (t = 2.0, p = 0.10). Subjects with dementia (N = 7; 4 M/3F; age = 68.6 ± 8.6 years) showed significant elevation in RVI-AD (t = 4.2, p = 3·10) but not RVI-MDD (t = 2.1, p = 0.10) compared to controls. Even within affective illnesses, participants with bipolar disorder (N = 54) and anxiety disorder (N = 773) showed no significant elevation in whole-brain RVI-MDD. Participants with Parkinson's disease (N = 37) showed elevation in RVI-AD (t = 2.4, p = 0.01) while subjects with stroke (N = 247) showed no such elevation (t = 1.1, p = 0.3). In summary, we demonstrated elevation in RVI-MDD and RVI-AD measures in the respective illnesses with strong replicability that is relatively specific to the respective diagnoses. These neuroanatomic deviation patterns offer a useful biomarker for population-wide assessments of similarity to neuropsychiatric illnesses.
神经和精神疾病与区域性脑缺陷模式相关,这些模式具有独特的特征,并捕捉到特定疾病的特征。区域易损性指数(RVI)是通过比较个体的白质微观结构、皮质灰质厚度和皮质下灰质结构体积测量值与来自大规模荟萃分析研究的神经解剖学缺陷模式来量化脑相似性而开发的。我们在英国生物银行(UKBB)的大型流行病学样本中(N=19,393;9138M/10,255F;年龄=64.8±7.4 岁)对 RVI 方法用于重度抑郁症(MDD)和阿尔茨海默病(AD)的特异性进行了测试。与无神经精神疾病的对照组相比,患有 MDD 的参与者(N=2,248;805M/1443F;年龄=63.4±7.4 岁)的 RVI-MDD 值明显更高(t=5.6,p=1·10),但在 RVI-AD 中没有检测到差异(t=2.0,p=0.10)。患有痴呆症的受试者(N=7;4M/3F;年龄=68.6±8.6 岁)的 RVI-AD 值明显升高(t=4.2,p=3·10),而 RVI-MDD 值无明显升高(t=2.1,p=0.10)与对照组相比。即使在情感障碍中,患有双相情感障碍(N=54)和焦虑症(N=773)的参与者的全脑 RVI-MDD 也没有明显升高。患有帕金森病(N=37)的参与者的 RVI-AD 值升高(t=2.4,p=0.01),而患有中风的参与者(N=247)则没有升高(t=1.1,p=0.3)。总之,我们在各自的疾病中发现了 RVI-MDD 和 RVI-AD 测量值的升高,并且具有较强的可重复性,相对特异性地与各自的诊断相关。这些神经解剖偏差模式为人群对神经精神疾病相似性的评估提供了有用的生物标志物。